Literature DB >> 19417559

Role of Src family kinases in acquired resistance to EGFR therapies in cancer.

Julie L Boerner1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19417559     DOI： 10.4161/cbt.8.8.8183

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN： 1538-4047            Impact factor:   4.742


× No keyword cloud information.
  7 in total

1.  CRIPTO1 expression in EGFR-mutant NSCLC elicits intrinsic EGFR-inhibitor resistance.

Authors:  Kang-Seo Park; Mark Raffeld; Yong Wha Moon; Liqiang Xi; Caterina Bianco; Trung Pham; Liam C Lee; Tetsuya Mitsudomi; Yasushi Yatabe; Isamu Okamoto; Deepa Subramaniam; Tony Mok; Rafael Rosell; Ji Luo; David S Salomon; Yisong Wang; Giuseppe Giaccone
Journal:  J Clin Invest       Date:  2014-06-09       Impact factor: 14.808

2.  CXCL12/SDF-1α induces migration via SRC-mediated CXCR4-EGFR cross-talk in gastric cancer cells.

Authors:  Yu Cheng; Jinglei Qu; Xiaofang Che; Ling Xu; Na Song; Yanju Ma; Jing Gong; Xiujuan Qu; Yunpeng Liu
Journal:  Oncol Lett       Date:  2017-06-15       Impact factor: 2.967

Review 3.  Rechallenge therapy and treatment holiday: different strategies in management of metastatic colorectal cancer.

Authors:  Giuseppe Tonini; Marco Imperatori; Bruno Vincenzi; Anna Maria Frezza; Daniele Santini
Journal:  J Exp Clin Cancer Res       Date:  2013-11-18

4.  CUB domain-containing protein 1 and the epidermal growth factor receptor cooperate to induce cell detachment.

Authors:  Mary E Law; Renan B Ferreira; Bradley J Davis; Paul J Higgins; Jae-Sung Kim; Ronald K Castellano; Sixue Chen; Hendrik Luesch; Brian K Law
Journal:  Breast Cancer Res       Date:  2016-08-05       Impact factor: 6.466

5.  Combined targeting EGFR and SRC as a potential novel therapeutic approach for the treatment of triple negative breast cancer.

Authors:  Alexandra Canonici; Alacoque L Browne; Mohamed F K Ibrahim; Kevin P Fanning; Sandra Roche; Neil T Conlon; Fiona O'Neill; Justine Meiller; Mattia Cremona; Clare Morgan; Bryan T Hennessy; Alex J Eustace; Flavio Solca; Norma O'Donovan; John Crown
Journal:  Ther Adv Med Oncol       Date:  2020-01-28       Impact factor: 8.168

6.  Upregulation of Serine Proteinase Inhibitor Clade B Member 3 (SERPINB3) Expression by Stromal Cell-Derived Factor (SDF-1)/CXCR4/Nuclear Factor kappa B (NF-κB) Promotes Migration and Invasion of Gastric Cancer Cells.

Authors:  Jing Gong; Yongxi Song; Ling Xu; Xiaofang Che; Kezuo Hou; Tianshu Guo; Yu Cheng; Yunpeng Liu; Xiujuan Qu
Journal:  Med Sci Monit       Date:  2020-10-28

7.  EGFR Alterations Influence the Cetuximab Treatment Response and c-MET Tyrosine-Kinase Inhibitor Sensitivity in Experimental Head and Neck Squamous Cell Carcinomas.

Authors:  Györgyi A Nelhűbel; Mihály Cserepes; Balázs Szabó; Dóra Türk; Adél Kárpáti; István Kenessey; Erzsébet Rásó; Tamás Barbai; Zita Hegedűs; Viktória László; Bálint Szokol; Judit Dobos; László Őrfi; József Tóvári
Journal:  Pathol Oncol Res       Date:  2021-05-03       Impact factor: 3.201
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.